Genzo Iguchi

3.0k total citations
104 papers, 2.3k citations indexed

About

Genzo Iguchi is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Genzo Iguchi has authored 104 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Endocrinology, Diabetes and Metabolism, 23 papers in Molecular Biology and 20 papers in Surgery. Recurrent topics in Genzo Iguchi's work include Growth Hormone and Insulin-like Growth Factors (43 papers), Pituitary Gland Disorders and Treatments (41 papers) and Adrenal Hormones and Disorders (18 papers). Genzo Iguchi is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (43 papers), Pituitary Gland Disorders and Treatments (41 papers) and Adrenal Hormones and Disorders (18 papers). Genzo Iguchi collaborates with scholars based in Japan, United States and Australia. Genzo Iguchi's co-authors include Yutaka Takahashi, Hidenori Fukuoka, Hitoshi Nishizawa, Michiko Takahashi, Yasuhiko Okimura, Kentaro Suda, Hironori Bando, Hidesuke Kaji, Kazuo Chihara and Masaaki Yamamoto and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Genzo Iguchi

100 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Genzo Iguchi Japan 28 1.1k 657 501 467 337 104 2.3k
Kàroly Rácz Hungary 28 1.0k 0.9× 445 0.7× 1.1k 2.1× 154 0.3× 725 2.2× 162 2.9k
Luisella Alberti Italy 26 625 0.6× 343 0.5× 997 2.0× 192 0.4× 284 0.8× 41 2.1k
Omar Serri Canada 26 1.9k 1.8× 514 0.8× 279 0.6× 212 0.5× 797 2.4× 81 2.5k
Helen Imrie United Kingdom 22 551 0.5× 235 0.4× 376 0.8× 367 0.8× 165 0.5× 39 1.6k
Lynn A. Burmeister United States 25 1.2k 1.1× 204 0.3× 332 0.7× 242 0.5× 301 0.9× 64 1.9k
Frédéric Leprêtre France 21 177 0.2× 473 0.7× 690 1.4× 460 1.0× 244 0.7× 47 1.8k
Billie M. Moats‐Staats United States 24 988 0.9× 175 0.3× 796 1.6× 293 0.6× 485 1.4× 46 2.1k
J. Zapf Switzerland 22 1.3k 1.2× 287 0.4× 831 1.7× 552 1.2× 314 0.9× 39 2.3k
Sergio Li Calzi United States 29 680 0.6× 146 0.2× 1.5k 2.9× 295 0.6× 640 1.9× 59 2.9k
Ju Hee Lee South Korea 23 246 0.2× 415 0.6× 694 1.4× 610 1.3× 307 0.9× 94 2.1k

Countries citing papers authored by Genzo Iguchi

Since Specialization
Citations

This map shows the geographic impact of Genzo Iguchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Genzo Iguchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Genzo Iguchi more than expected).

Fields of papers citing papers by Genzo Iguchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Genzo Iguchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Genzo Iguchi. The network helps show where Genzo Iguchi may publish in the future.

Co-authorship network of co-authors of Genzo Iguchi

This figure shows the co-authorship network connecting the top 25 collaborators of Genzo Iguchi. A scholar is included among the top collaborators of Genzo Iguchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Genzo Iguchi. Genzo Iguchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Iguchi, Genzo, et al.. (2025). Anti-PIT1 hypophysitis after immune checkpoint inhibitor treatment. Nature Reviews Endocrinology. 21(5). 265–266. 2 indexed citations
2.
Kanie, Keitaro, Takeshi Itoh, Genzo Iguchi, et al.. (2025). Modeling of T cell-mediated autoimmune pituitary disease using human induced pluripotent stem cell-originated organoid. Nature Communications. 16(1). 7900–7900. 1 indexed citations
3.
Yamamoto, Naoki, Hironori Bando, Masaaki Yamamoto, et al.. (2024). Metyrapone single administration, as a possible predictive tool of its dosage and timing in Cushing’s syndrome. Frontiers in Endocrinology. 15. 1511155–1511155.
4.
Bando, Hironori, et al.. (2024). Acquired isolated ACTH deficiency co-occurrence with breast cancer irrespective of paraneoplastic syndrome: coincidence or inevitability. Endocrinology Diabetes and Metabolism Case Reports. 2024(3). 1 indexed citations
5.
Bando, Hironori, Masaaki Yamamoto, Masaki Suzuki, et al.. (2024). Diagnostic dilemma in Cushing’s syndrome: discrepancy between patient-reported and physician-assessed manifestations. Endocrine. 86(1). 417–427.
6.
Kanzawa, Maki, Keitaro Kanie, Masaaki Yamamoto, et al.. (2024). Effects of the Cortisol Milieu on Tumor-Infiltrating Immune Cells in Corticotroph Tumors. Endocrinology. 165(4). 1 indexed citations
7.
Bando, Hironori, Maki Kanzawa, Hidenori Fukuoka, et al.. (2024). The early‐stage clinical course of anti‐pituitary‐specific transcription factor‐1 hypophysitis diagnosed post‐immune checkpoint inhibitor treatment: A case with review of literature. Journal of Neuroendocrinology. 36(6). e13395–e13395. 2 indexed citations
8.
Iguchi, Genzo, Keitaro Kanie, Hironori Bando, et al.. (2023). Clinical features of anti-pituitary-specific transcription factor-1 (PIT-1) hypophysitis: a new aspect of paraneoplastic autoimmune condition. European Journal of Endocrinology. 190(1). K1–K7. 7 indexed citations
9.
Fukuoka, Hidenori, Maki Kanzawa, Masaaki Yamamoto, et al.. (2022). Responsiveness to DDAVP in Cushing’s disease is associated with USP8 mutations through enhancing AVPR1B promoter activity. Pituitary. 25(3). 496–507. 9 indexed citations
10.
Suzuki, Masaki, Hidenori Fukuoka, Yushi Hirota, et al.. (2022). Relation between the insulin lowering rate and changes in bone mineral density: Analysis among subtypes of type 1 diabetes mellitus. Journal of Diabetes Investigation. 13(9). 1585–1595. 3 indexed citations
11.
Kanie, Keitaro, Genzo Iguchi, Hironori Bando, et al.. (2021). Mechanistic insights into immune checkpoint inhibitor-related hypophysitis: a form of paraneoplastic syndrome. Cancer Immunology Immunotherapy. 70(12). 3669–3677. 45 indexed citations
12.
Suda, Kentaro, Hidenori Fukuoka, Genzo Iguchi, et al.. (2020). A Case of Luscan-Lumish Syndrome: Possible Involvement of Enhanced GH Signaling. The Journal of Clinical Endocrinology & Metabolism. 106(3). 718–723. 5 indexed citations
13.
Suda, Kentaro, Hidenori Fukuoka, Yuto Yamazaki, et al.. (2020). Cardiac Myxoma Caused by Fumarate Hydratase Gene Deletion in Patient With Cortisol-Secreting Adrenocortical Adenoma. The Journal of Clinical Endocrinology & Metabolism. 105(6). 1957–1962. 2 indexed citations
14.
Yamada, Tomoko, Hidenori Fukuoka, Yukiko Odake, et al.. (2020). Patients with pheochromocytoma exhibit low aldosterone renin ratio-preliminary reports. BMC Endocrine Disorders. 20(1). 140–140. 2 indexed citations
15.
Kanie, Keitaro, Genzo Iguchi, Megumi Inuzuka, et al.. (2020). Two Cases of anti–PIT-1 Hypophysitis Exhibited as a Form of Paraneoplastic Syndrome not Associated With Thymoma. Journal of the Endocrine Society. 5(3). bvaa194–bvaa194. 12 indexed citations
16.
Matsumoto, Ryusaku, Hidetaka Suga, Takashi Aoi, et al.. (2019). Congenital pituitary hypoplasia model demonstrates hypothalamic OTX2 regulation of pituitary progenitor cells. Journal of Clinical Investigation. 130(2). 641–654. 40 indexed citations
17.
Matsumoto, Ryusaku, Hidenori Fukuoka, Genzo Iguchi, et al.. (2015). Accelerated Telomere Shortening in Acromegaly; IGF-I Induces Telomere Shortening and Cellular Senescence. PLoS ONE. 10(10). e0140189–e0140189. 30 indexed citations
18.
Kishimoto, Miyako, Yasuhiko Okimura, Genzo Iguchi, et al.. (2003). The R271W mutant form of Pit-1 does not act as a dominant inhibitor of Pit-1 action to activate the promoters of GH and prolactin genes. European Journal of Endocrinology. 148(6). 619–625. 11 indexed citations
19.
Okimura, Yasuhiko, Hirohisa Nakata, Takumi Kudo, et al.. (2003). Cloning and characterization of the 5′-flanking region of the human ghrelin gene. Biochemical and Biophysical Research Communications. 305(1). 186–192. 67 indexed citations
20.
Okimura, Yasuhiko, Kazuhiro Yagita, Genzo Iguchi, et al.. (2002). Novel Function of the Transactivation Domain of a Pituitary-specific Transcription Factor, Pit-1. Journal of Biological Chemistry. 277(47). 45141–45148. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026